These innovative medications , Tirzepatide , represent a groundbreaking advancement in treating metabolic dysfunction and conceivably other disorders. They are grouped as GLP-1 receptor activators , meaning these substances to emulate the body's GLP-1 peptide, enhancing metabolic release and lowering food intake. While Semaglutide each works largel